IMTX

Immatics NV

10.12
0.00 (0.0%)

Immatics N.V. (IMTX) Fundamentals

Immatics NV is engaged in the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's pipeline consists of two lead product classes, engineered Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics (TCER). Each therapeutic modality has distinct attributes to produce the desired therapeutic effect for patients at different disease stages and with different types of tumors focusing on particularly hard-to-treat solid cancers.
SHARE INFORMATION
Market Cap$ 775,900,400
Shares Outstanding76,670,000
Float56,723,165
Percent Float73.98%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.56
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions122
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months9,785,894
Institutional Holdings Percent52.1%
Institutional Sold Previous 3 Months1,871,065
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 13.60
52 Week Low$ 5.90
52 Week High Change$ 34.04
21 Day Moving Average$ 9.8121
21 Day Extended Moving Average$ 9.4705
50 Day Moving Average$ 8.1387
50 Day Extended Moving Average$ 8.7887
200 Day Moving Average$ 9.3836
200 Day Extended Moving Average$ 8.9666
10 Day Average Volume407,085
20 Day Average Volume361,763
30 Day Average Volume503,832
50 Day Average Volume463,394
Alpha0.000347
Beta0.6689
Standard Deviation0.145433
R20.058473
7 Day Price Change$ 0.67
7 Day Percent Change7.09%
21 Day Price Change$ 0.65
21 Day Percent Change6.86%
30 Day Price Change$ 2.80
30 Day Percent Change38.25%
Month to Date Price Change$ 0.25
Month to Date Percent Change2.53%
Quarter to Date Price Change$ 3.22
Quarter to Date Percent Change46.67%
180 Day Price Change$ -1.07
180 Day Percent Change-9.56%
200 Day Price Change$ -0.34
200 Day Percent Change-3.25%
Year to Date Price Change$ 1.41
Year to Date Percent Change16.19%

Immatics N.V. (IMTX) Key Ratios

PROFITABILITY
EBIT Margin39.4%
EBITDA Margin43.2%
Pre-Tax Profit Margin-129.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 126.75
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.50
Total Debt To Equity0.10
Int Coverage78.10
Current Ratio3.50
Leverage Ratio1.90
Quick Ratio1.40
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio12.20
Enterprise Value$ 622,775,900
Price to Sales4.57
Price to Free Cash0.00
PE High Last 5 Years1.40
Price To Book3.50
Price To Cash Flow0.00
PE Low Last 5 Years-12.50
Price to Tangible Book3.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover150.80
Invoice Turnover0.00
Assets Turnover0.50
Return Assets17.42
Return on Equity42.66
Return on Capital0.00

Immatics N.V. (IMTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft
CEOHarpreet Singh
Employees255
Last Audit-
CIK0001809196
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
AddressPaul-Ehrlich-Straÿe 15
Tubingen, BW 72076
Websitehttps://www.immatics.com
Facsimile+49 70715397900
Telephone+49 707153970
Email-


Your Recent History
NASDAQ
IMTX
Immatics N..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.